|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2005;79:2201-2202
© 2005 The Society of Thoracic Surgeons
Department of Surgery, University Hospital of Geneva, Geneva, CH 1211 Switzerland
(E-mail: beat.walpoth@hcuge.ch).
| The first 20% of the full text of this article appears below. |
To the Editor:
Schachner and colleagues [1] have shown in an elegant experimental study that rapamycin could inhibit the development of neointimal hyperplasia in vein grafts. This was done in a mouse autologous graft transplantation model (vein to artery), with and without a peri-paravascular application of rapamycin. Significant reduction of neointimal hyperplasia was observed in the
Related Article
Ann. Thorac. Surg. 2005 79: 2202.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |